AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,416 | -73.1% | 25,200 | 0.0% | 0.02% | -72.9% |
| Q2 2023 | $1,133,244 | -4.3% | 25,200 | -4.3% | 0.06% | -14.5% |
| Q1 2023 | $1,184,516 | +0.4% | 26,346 | +1.4% | 0.07% | -4.2% |
| Q4 2022 | $1,179,868 | +2.3% | 25,994 | -13.9% | 0.07% | -12.2% |
| Q3 2022 | $1,153,000 | +273.1% | 30,200 | 0.0% | 0.08% | +272.7% |
| Q2 2022 | $309,000 | +17.0% | 30,200 | 0.0% | 0.02% | +10.0% |
| Q1 2022 | $264,000 | -51.8% | 30,200 | 0.0% | 0.02% | -48.7% |
| Q4 2021 | $548,000 | -26.8% | 30,200 | 0.0% | 0.04% | -26.4% |
| Q3 2021 | $749,000 | -43.0% | 30,200 | -50.0% | 0.05% | +8.2% |
| Q2 2021 | $1,314,000 | +44.1% | 60,400 | +100.0% | 0.05% | -34.7% |
| Q1 2021 | $912,000 | -2.8% | 30,200 | 0.0% | 0.08% | -15.7% |
| Q4 2020 | $938,000 | +12.6% | 30,200 | 0.0% | 0.09% | -10.1% |
| Q3 2020 | $833,000 | -27.6% | 30,200 | 0.0% | 0.10% | -31.2% |
| Q2 2020 | $1,150,000 | +85.2% | 30,200 | 0.0% | 0.14% | +50.0% |
| Q1 2020 | $621,000 | +4.4% | 30,200 | 0.0% | 0.10% | +31.5% |
| Q4 2019 | $595,000 | -6.4% | 30,200 | 0.0% | 0.07% | -18.9% |
| Q3 2019 | $636,000 | -5.9% | 30,200 | 0.0% | 0.09% | -7.2% |
| Q2 2019 | $676,000 | – | 30,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |